Bausch Health Companies Inc. plans to build on the market share it's gained in OTC eye drops with the Lumify brand with a line extension to treat allergy symptoms as well as redness.
While Lumify (brimonidine tartrate ophthalmic solution 0.025%) has reached 35% market share in US OTC eye drops since its launch in May 2018, the Canadian firm's top consumer health products, and the No
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?